(Press-News.org) The Lancet: New weight loss pill leads to greater blood sugar control and weight loss for people with diabetes than current oral GLP-1, phase 3 trial finds
A novel GLP-1 receptor agonist (RA) pill called orforglipron leads to a larger reduction in blood sugar levels after a year than the current available oral GLP-1 RA (semaglutide), finds a phase 3 randomised controlled trial published in The Lancet. Additionally, participants taking orforglipron had significantly greater reductions in body weight than those taking oral semaglutide.
Currently the only available oral GLP-1 RA is semaglutide which must be taken on an empty stomach. Orforglipron is an alternative oral GLP-1 RA that can be taken with or without food and is currently under review with the FDA. ACHIEVE-3 is the first phase 3 trial to directly compare orforglipron (12 or 36 mg) with oral semaglutide (7 or 14 mg).
In the trial, over 1,500 people with type 2 diabetes from 131 medical research centres and hospitals in Argentina, China, Japan, Mexico, and the USA were randomised to take orforglipron at one of the two doses or semaglutide at one of two doses for a year.
The participants who took orforglipron had, on average, a greater drop in blood sugar levels for both doses than either of the doses of semaglutide. Patients, starting at an average weight of 97kg, lost on average 6-8% of their weight with orforglipron and 4-5% with semaglutide. However, 9-10% of participants in the orforglipron groups stopped taking the pill due to adverse events (mostly gastrointestinal issues), compared to 4-5% in the semaglutide groups.
Authors say that orforglipron could be a new treatment option for people with type 2 diabetes who prefer a pill to an injection and do not want any restrictions on food and fluid intake.
END
The Lancet: New weight loss pill leads to greater blood sugar control and weight loss for people with diabetes than current oral GLP-1, phase 3 trial finds
2026-02-26
ELSE PRESS RELEASES FROM THIS DATE:
Pediatric investigation study highlights two-way association between teen fitness and confidence
2026-02-26
Physical fitness and psychological resilience develop side by side during adolescence, a life stage that lays the foundation for adult health. Cardiorespiratory endurance, muscular strength, and agility are well-known predictors of cardiometabolic health, while self-efficacy, defined as the belief in one’s ability to overcome challenges, shapes motivation, persistence, and coping strategies. Although both have independently been linked to healthier lifestyles and improved well-being, less attention has been given to how they may influence ...
Researchers develop cognitive tool kit enabling early Alzheimer's detection in Mandarin Chinese
2026-02-26
Asian Americans are the fastest-growing group of older adults in the U.S., but they often face language and cultural barriers when seeking care for dementia-related symptoms.
As part of a broader mission to tackle these challenges, a Rutgers Health-led study involving internationally renowned clinicians and scientists from the National Institute on Aging-funded Rutgers-NYU Resource Center for Alzheimer’s Disease and Research Center in Asian and Pacific Americans and Stanford Alzheimer’s Disease Research Center has proposed a ...
New book captures hidden toll of immigration enforcement on families
2026-02-26
“They took Dad.”
That sentence opens Carolina Valdivia’s new book, Sanctuary Making: Immigrant Families Reshaping Geographies of Deportability, published this month by the University of California Press.
The book chronicles what happens to families in the aftermath of those three words, and the extraordinary lengths that ordinary people go to in order to protect the ones they love.
“This is a book with a sense of urgency” wrote Emmy Award–winning journalist and former Univision News anchor Jorge Ramos in his review. “From the first line — ...
New record: Laser cuts bone deeper than before
2026-02-26
Lasers cut precisely and without contact – ideal for surgery. The problem is that, in hard tissues such as bone, they are too slow and do not cut deep enough. Researchers at the University of Basel have now demonstrated a way to cut much deeper and faster with a surgical laser than with previous laser systems.
The saw, chisel and drill are tried-and-true tools in bone surgery. In the future, lasers could be added to this toolbox, especially when it comes to very precise cuts. Lasers do not exert any mechanical pressure, meaning they can reduce the risk of ...
Heart attack deaths rose between 2011 and 2022 among adults younger than age 55
2026-02-26
Research Highlights:
In an analysis of data from 2011 to 2022, the number of deaths after first hospitalization for a severe heart attack increased significantly among men and women ages 18-54.
At the same time, the number of deaths was higher among women than men in this age range for both a heart attack caused by a complete blockage of a coronary artery and one resulting from a partial coronary artery blockage.
After accounting for all risk factors assessed, heart attack deaths remained linked to more nontraditional risk factors—including low income, kidney disease and non-tobacco drug use—rather than traditional risk factors, such as high blood pressure or high cholesterol, ...
Will melting glaciers slow climate change? A prevailing theory is on shaky ground
2026-02-26
For scientists who study the Southern Ocean, a long-standing silver lining in the gloomy forecast of climate change has been the theory of iron fertilization. As temperatures rise and glaciers in Antarctica melt, ice-trapped iron would feed blooms of microscopic algae, pulling heat-trapping carbon dioxide from the atmosphere as they grow.
There’s just one problem: The theory doesn’t hold water.
In what researchers describe as the most accurate measurement of iron inputs from a glacier in Antarctica, marine scientists from Rutgers University-New Brunswick have discovered that meltwater from an Antarctic ice shelf supplies far less iron to surrounding ...
New treatment may dramatically improve survival for those with deadly brain cancer
2026-02-26
LOS ANGELES — High-grade astrocytoma, which includes glioblastoma, is a fast-growing, aggressive brain cancer that often returns after the tumor is removed, making it difficult to treat. Patients with recurrent high-grade astrocytoma typically only survive for four to five months.
Immune checkpoint inhibitors, medications that allow the body’s own immune system, particularly cancer-fighting T-cells, to recognize, find and attack tumor cells, can help stop ...
Here we grow: chondrocytes’ behavior reveals novel targets for bone growth disorders
2026-02-26
Osaka, Japan – Achondroplasia, also known as short-limb dwarfism, is associated with neurological symptoms and complications due to narrowing of the skeletal structures surrounding the spinal cord. Despite achondroplasia being the most common cause of dwarfism, the mechanisms underlying the condition remain to be analyzed, meaning that current treatment options are insufficient.
Now, a team at The University of Osaka has created a mouse model of achondroplasia that has advanced understanding of ...
Leaping puddles create new rules for water physics
2026-02-26
Water droplets have a unique ability: They can leap from a surface on their own.
This can happen for a variety of reasons, such as when a surface repels water or when heat is involved, such as a water or oil droplet skittering across a hot pan.
It also happens at a very small scale. Up to this point, researchers have observed droplets up to 3 millimeters in diameter exhibiting this behavior. When droplets are larger than that, gravity prevents it from jumping.
A new study published in Nature identifies a previously unreported way to get a puddle of water up to a centimeter wide to jump into the air, something ...
Scientists identify key protein that stops malaria parasite growth
2026-02-26
An international team of scientists has shed light on the development of the malaria parasite and have identified a unique protein essential for its survival and transmission, which offers a promising new target for antimalaria drugs.
The discovery centres on a molecule named Aurora-related kinase 1 (ARK1). In a new study published in Nature Communications, researchers from the University of Nottingham, National Institute of Immunology (NII), India, University of Groningen, the Netherlands, the Francis Crick Institute, and international collaborators, have revealed that ARK1 acts as a ‘traffic controller’ during the parasite's unusual cell division and growth process.
Malaria ...